Abstract 2898 Identification of Methylation Patterns, Associated DNA Methylating Proteins, and Methyltransferase Inhibitors on the Promoter Regions of DAX-1

The DAX-1 gene (Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X chromosome, gene 1) encodes for an orphan nuclear hormone receptor and its mutation is implicated in multiple diseases including congenital adrenal hypoplasia, adrenal cancer, and breast cancer. Previous research has linked DAX-1 downregulation to tumor initiation in breast tissue, suggesting the gene acts as a tumor suppressor with respect to breast cancer. Additional studies completed by the Tzagarakis-Foster Laboratory have shown that methylation of the DAX-1 promoter region is heavily influential in breast cancer development, with release of epigenetic repression resulting in slowing of cellular proliferation and tumor progression.

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jbc.2025.109315
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 2898 Identification of Methylation Patterns, Associated DNA Methylating Proteins, and Methyltransferase Inhibitors on the Promoter Regions of DAX-1

Christina Tzagarakis-Foster, Brandon Toy, Jack Akmakjian, Enguun Boldbaatar
Journal of Biological Chemistry
Cancer, Hypoxia, and Metabolism
article

Abstract 2898 Identification of Methylation Patterns, Associated DNA Methylating Proteins, and Methyltransferase Inhibitors on the Promoter Regions of DAX-1

Christina Tzagarakis-Foster, Brandon Toy, Jack Akmakjian, Enguun Boldbaatar
article en

Abstract

The DAX-1 gene (Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X chromosome, gene 1) encodes for an orphan nuclear hormone receptor and its mutation is implicated in multiple diseases including congenital adrenal hypoplasia, adrenal cancer, and breast cancer. Previous research has linked DAX-1 downregulation to tumor initiation in breast tissue, suggesting the gene acts as a tumor suppressor with respect to breast cancer. Additional studies completed by the Tzagarakis-Foster Laboratory have shown that methylation of the DAX-1 promoter region is heavily influential in breast cancer development, with release of epigenetic repression resulting in slowing of cellular proliferation and tumor progression.

Journal of Biological ChemistryVol. 301(5)
Case Western Reserve University (US)
National Science Foundation, National Institutes of Health, National Institute of General Medical Sciences
Openalex Percentile: Top 82%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.